This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug DETRUSITOL contains one active pharmaceutical ingredient (API):
1
|
UNII
5T619TQR3R - TOLTERODINE TARTRATE
|
|
Tolterodine is a competitive, specific muscarinic receptor antagonist with selectivity for the urinary bladder over salivary glands in vivo. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G04BD07 | Tolterodine | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 552820050066717 |
| DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 00234672, 01811290, 01812390, 01812409, 03161873, 04707009, 06306562, 07631620, 08624384, 08759931, 08759954, 08922489, 08922503, 11580420, 11580437, 11580443, 13899746 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 27.632-1-11-11, 30072-12-11 |
| EE | Ravimiamet | 1043301, 1043312, 1064146, 1064157 |
| ES | Centro de información online de medicamentos de la AEMPS | 2383602, 62022, 64245 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 002531, 004891, 048827 |
| FR | Base de données publique des médicaments | 64617270 |
| GB | Medicines & Healthcare Products Regulatory Agency | 138639, 138642, 138644, 143057, 143067, 143072, 19968, 19970, 373747, 398233 |
| HK | Department of Health Drug Office | 43721, 43722, 66981, 66982 |
| IE | Health Products Regulatory Authority | 20469, 20470, 53615, 53617, 53627, 53651, 53662, 53693 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 4533, 4534 |
| JP | 医薬品医療機器総合機構 | 2590012M1021, 2590012M2028 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1004484, 1004538, 1005550, 1026187, 1026188, 1037880, 1037882, 1072504, 1092956, 1092957 |
| MT | Medicines Authority | MA1396/00501, MA1396/00502 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 176M98, 194M2004 |
| NL | Z-Index G-Standaard, PRK | 50334, 50342, 60534, 66842 |
| NZ | Medicines and Medical Devices Safety Authority | 8037, 8038 |
| SG | Health Sciences Authority | 09911P, 09912P, 11857P, 11859P |
| TN | Direction de la Pharmacie et du Médicament | 7963061, 7963062 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699532014092, 8699532178169, 8699532178404, 8699759090022, 8699759090046 |
| ZA | Health Products Regulatory Authority | 36/5.1/0449, 36/5.4/0448 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.